Zimmer Biomet Holdings

Zimmer Biomet Holdings

Develops medical devices for musculoskeletal health

About Zimmer Biomet Holdings

Simplify's Rating
Why Zimmer Biomet Holdings is rated
A-
Rated B on Competitive Edge
Rated A on Growth Potential
Rated A on Rating Differentiation

Industries

Biotechnology

Healthcare

Company Size

10,001+

Company Stage

IPO

Headquarters

Warsaw, Indiana

Founded

1927

Overview

Zimmer Biomet focuses on providing solutions in the musculoskeletal healthcare field, particularly in joint replacement, surgical trauma, and sports medicine. Their products include robotically assisted surgeries and smart implants, which enhance the precision and effectiveness of medical procedures. Unlike many competitors, Zimmer Biomet has a long history of over 90 years in the industry, allowing them to build strong relationships with hospitals, surgical centers, and orthopedic specialists worldwide. The company's goal is to improve healthcare outcomes through ongoing innovation and collaboration with healthcare professionals.

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased telemedicine adoption boosts demand for Zimmer Biomet's smart implants and connected devices.
  • The global orthopedic devices market is expected to grow, benefiting Zimmer Biomet's revenue.
  • AI integration in surgeries enhances precision, favoring Zimmer Biomet's robotic surgery investments.

What critics are saying

  • Increased competition could impact Zimmer Biomet's market share in orthopedic sectors.
  • The CPT Hip System recall may lead to reputational damage and financial losses.
  • Paragon 28 acquisition could pose integration challenges and financial strain.

What makes Zimmer Biomet Holdings unique

  • Zimmer Biomet specializes in innovative solutions for joint replacement and sports medicine.
  • The company offers advanced technologies like robotically assisted surgeries and smart implants.
  • Zimmer Biomet has over 90 years of experience in the musculoskeletal healthcare industry.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$1000M

Above

Industry Average

Funded Over

1 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison
Coming Soon

Company News

MarketBeat
Mar 8th, 2025
AMG National Trust Bank Invests $3.70 Million in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

AMG National Trust Bank invests $3.70 Million in Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

BioSpace
Mar 6th, 2025
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer

Ms. Cardillo joins Zimmer Biomet from life science tools company 10x Genomics, where she was Vice President of Corporate Communications.

Indiana Chamber of Commerce
Mar 4th, 2025
Hamilton Named a Finalist in EXHIBITOR's Portable/Modular Awards

INDIANAPOLIS - Hamilton is honored to announce that Indiana Chamber has been selected as a finalist in EXHIBITOR's 12th Annual Portable/Modular Awards for the Island Exhibit 3,300 s.f. or More category.

ODT Magazine
Feb 27th, 2025
Zimmer Biomet Names New SVP, Chief Strategy, Innovation & Business Development Officer

Zimmer Biomet Holdings has appointed Jehanzeb Noor as the Senior Vice President, Chief Strategy, Innovation, and Business Development Officer.

BW Legal World
Feb 24th, 2025
Vivek Malhotra Appointed Director - Legal (South Asia) At Zimmer Biomet

Vivek Malhotra has been appointed as the Director - Legal (South Asia) at Zimmer Biomet, a publicly traded American medical device company founded in 1927 and headquartered in Warsaw, Indiana.

There are no jobs for Zimmer Biomet Holdings right now.

Find jobs on Simplify and start your career today

💡
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →